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Background: The literature has increasingly discussed alternative approaches to analyze 
and evaluate healthcare investments in state-of-the-art technologies, especially with the 
advent of Healthcare 4.0 technologies or e-health. Such investments generally involve 
computer hardware and software that deals with the storage, retrieval, sharing, and use of 
healthcare information, data, and knowledge for communication and decision-making. 
Besides, the utility of these technologies significantly increases when addressed in 
bundles. However, a structured and holistic approach for analyzing investments in 
Healthcare 4.0 technologies is not available in the literature. 
 
Objective: This study aims to analyze previous research related to the evaluation of 
Healthcare 4.0 technologies in hospitals and characterize the most common investment 
approaches used. We propose a framework that organizes the research associated with 
Hospitals 4.0 investment decisions and suggest five main research directions on the topic. 
 
Method: To achieve our goal, we carried out the standard procedure for scoping reviews. 
We performed a search in the Crossref, PubMed, Scopus, and Web of Science databases 
with the keywords "investment," "health," "industry 4.0," "investment," "health 
technology assessment," "healthcare 4.0," and "smart" in the title, abstract, and keywords 
of research papers. We retrieved 5701 publications from all databases. After removing 
papers prior to 2011, duplicates, and performing further screening, we arrived at 244 
articles from which 33 were selected after in-depth analysis to compose the final 
publications' portfolio. 
 
Results: Our findings show the multidisciplinary nature of the research related to 
evaluating hospital investments in H4.0. We detect that the most common investment 
approaches focused on cost analysis, single technology, and single decision-maker 
involvement, which dominates over bundle analysis, H4.0 value considerations, and 
multiple decision-maker involvement. We propose a framework for clasifying H4.0 
investment methodologies and suggest five main research directions for this topic. 
 
Conclusions: Some of our findings were unexpected given the interrelated nature of H4.0 
and its multidimensional impact. Given the absence of a more holistic approach for H4.0 
investment decisions, we identified five promising research directions on the topic: (i) 
development of economic valuation methodologies tailored for healthcare 4.0 
technologies, (ii) account for technology interrelations in the form of bundles, (iii) 
account for uncertainties in the process of evaluating such technologies, (iv) integration 
of administrative, medical and patient perspectives into the evaluation process, and (v) 
balancing and handling of complexity in the decision-making process. 
 
Keywords: H4.0, Investments, Real Options, Health Technology Assessment, 
Technological Bundles, Decision-Makers. 
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Introduction 
How do health organizations manage and determine their investment decisions in 
Industry 4.0 technologies (known as Healthcare 4.0 or H4.0)? Having the right answer to 
this question is essential since the healthcare value chain is increasingly applying H4.0 
technologies [1]. Also, the rising demand for more efficient, qualified, and less expensive 
health services has motivated novel technological solutions [2]. Healthcare organizations 
have incorporated innovative technologies around the internet to facilitate and support 
more efficient and flexible processes, services, and products [3,4]. Such technologies 
started playing a pivotal role as enhancers of efficiency and quality in healthcare systems 
in the 1990s, culminating in what is currently known as "e-health" [5]. Healthcare 
institutions extend the emerging principles and technologies belonging to the Industry 4.0 
realm to healthcare as a continuous and disruptive process of innovation and 
transformation of the entire healthcare value chain  [6]. 
The magnitude of the technological shift, the scope of activities affected, and their 
interrelationships expose healthcare decision-makers to large and complex investment 
decision problems [7,8]. The scope of activities encompasses procedures, equipment, and 
processes used to deliver medical care [9]. The range of such investments usually involves 
computer hardware and software that deals with the storage, retrieval, sharing, and use of 
healthcare information, data, and knowledge for communication and decision-making 
[10]. Even though it is possible to identify stand-alone technologies under the H4.0 
umbrella, they tend to be highly interrelated, generating the need to assess them in 
bundles. Also, there is significant uncertainty on which technology will be the industry 
standard, adding an extra level of complexity to financial evaluations. 
Since the level of investment required to stay competitive with these new technologies is 
massive, health institutions and countries' financial budgets are constantly stressed. For 
instance, data from BRICS nations (i.e., Brazil, Russia, India, China, and South Africa) 
indicates that their average health expenditure grew from 5.41% of their GDP in 1995 to 
6.94% in 2013, and is forecasted to reach an average of 7.86% by 2025 [11]. Hence, there 
will be an increasing need for massive and interconnected investments that will impose 
non-trivial challenges in determining their value, optimum level, and implementation 
sequence. 
Several different theoretical lenses help to enlighten managers in their technological 
investments. The Health Technology Assessment International Policy Forum recently 
concluded that the assessment paradigms need to be more agile, helping healthcare 
systems understand the potential of innovations and ensure that their potential value is 
realized [12]. However, while the literature has suffered from balkanization since 
multiple alternative approaches have significantly grown during the last years, hospitals 
rarely have or use a systematic decision process for H4.0 investments, accounting for all 
organizational objectives and utilizing objective data [13,14]. 
This paper aims to address the current gap between the literature and practice by 
examining trends, challenges, and research opportunities in hospital investment 
valuations of H4.0 technologies. To achieve that goal, we opted to carry out a scoping 
review of the literature, which is appropriate for identifying and mapping critical concepts 
that underpin a specific research topic, especially in the absence of previous 
comprehensive studies [15,16]. More important, the scoping review approach is also 
suggested as an alternative to a systematic review when literature is vast, sparse, and 
complex [17,18], which is the case of investments in H4.0 [19].  
The research has been structured in the following manner. First, we proceed to motivate 
the study, present the protocol for the scoping review (i.e., the research method section) 
and summarize the manuscript selection process. Second, we define the research 
questions and identify the relevant studies, selecting the final list. Third, we present the 
main findings in a section devoted to the analysis of results, addressing the first two 
research questions. Fourth, we develop a framework that synthesizes the analysis and 
identifies promising research directions regarding the most crucial characteristics for 
evaluating investments in H4.0, addressing the third research question. 
Hospital investments, the fourth industrial revolution, and alternative evaluation 
approaches 
 
The advent of I4.0 technologies has significantly affected the global healthcare value 
chain. The recent integration of disruptive technologies derived from Industry 4.0 into 
healthcare systems aims at achieving virtualization to provide care in real-time [20]. 
Healthcare institutions have incorporated cyber-physical systems, cloud computing, the 
internet of things, and big data, among others, into healthcare processes, services, 
equipment, material, and people. H4.0 allowed establishing a smart system to monitor, 
track, and store patient records for ongoing care and analysis [21,22]. The combination 
of new technologies has expanded the scope of hospital activities. Economically, H4.0 
technologies come with a value proposition of simultaneously incrementing efficiency 
and quality of care while reducing operating costs [23]. 
However, healthcare institutions need to carry out substantial investments to achieve the 
economic gains associated with H4.0. In 2014, US healthcare expenditure was $3.0 
trillion and is forecasted to rise to $5.1 trillion in 2023, outpacing the expected GDP 
growth rate in the corresponding period [24,25]. These expenditures imply multiple 
investments that are not free of uncertainties since evaluating the impact on patient care 
is extremely difficult [26].  
The unique characteristics of H4.0 add a layer of evaluation complexity in an industry 
where assessing economic value was already challenging. For instance, studies on Health 
Technology Assessment (HTA) have primarily recognized that not every technological 
development results in net health gains [27]. The history of medicine and health counts 
many examples of technologies that did not produce the expected benefits or even proved 
harmful. On the other side, proving the effectiveness of technologies creates a continuous 
challenge for health systems since their application may require additional resources or 
the need to select between competing alternatives within the health system. 
The literature has examined how healthcare organizations struggle to benefit from 
investments in H4.0 technologies [28,29]. Therefore, the dramatic increase in firms' 
technology investments in the last years has not necessarily resulted in significant 
increase in productivity [30]. The complexity of understanding the economic impact of 
H4.0 resulted in non-trivial challenges to determine the policy and practice implications 
associated with them [31]. 
Organizations contribute significant financial resources to developing and implementing 
H4.0, and the potential for a negative return on investments or total implementation 
failure is a worrisome possibility [32]. Assessing technological investments is of great 
interest to hospital managers to raise capital to expand services [33]. With the rapid 
growth of e-health in developing countries, there is an urgent need for substantial 
evidence of its impact on justifying and guiding the investment of resources in such 
systems [26]. 
Studies evaluating H4.0 investments have taken different approaches. A wide array of 
manuscripts focuses on cost reduction evaluation. For instance, [34] report that healthcare 
decision-makers base their adoption decisions on cost-effectiveness and cost-
minimization analysis. The approach's main limitation is the focus on just one side of the 
decision (cost), underemphasizing value considerations.  
The real options approach to decision-making has been useful in capturing and valuing 
uncertainty in many operating decisions that decision-makers face [35]. Its utility 
emerges from the fact that real-options are contingent on future discretionary investment. 
The magnitude, timing, and schedule of investment outlay affect the value of firms' 
growth opportunities. Although correcting limitations from the cost perspectives, the real 
options approach increases the analytical effort organizations need to carry out economic 
evaluations. 
Besides, H4.0 requests multilateral stakeholder dialogue and collaboration that addresses 
health needs and product conceptualization [12]. The nature of H4.0 imposes challenges 
on how to assess the various aspects of technological value into the decision-making 
processes, so it simultaneously accounts for the input of physicians, patients, and society 
[36].  
Not surprisingly, despite the expected benefits of H4.0 technologies and the interest from 
hospitals and policymakers in implementing them, the uptake and adoption of these 
technologies have not always been consistent within the health care practice, and adoption 
of these technologies has lagged [37]. There is a need to synthesize research activities 
and evidence to clarify the evaluation process of H4.0 investment in hospitals. Our 
scoping review explored such knowledge gap by mapping the extent and nature of the 
available literature. For that, our study focused on literature evidence that approached the 
integration of H4.0 technologies investments into hospitals. 
Research method 
 
The scoping review design represents a methodology that allows assessing emerging 
evidence; therefore, it is a the first step in research development [16]. It is a relatively 
new approach to evidence synthesis and differs from systematic reviews in its purpose 
and aims. The purpose of a scoping review is to provide an overview of the available 
research evidence without producing a summary answer to a discrete research question 
[38]. The methodology can help answer broad questions and gather and assess 
information before conducting a systematic review. It is suitable for achieving several 
objectives such as identifying types of existing evidence in a given field, clarifying key 
concepts or definitions in the literature, surveying how research is conducted on a specific 
topic, identifying key characteristics related to a particular topic, and identifying 
knowledge gaps. Compared with systematic literature reviews and meta-analyses, a 
scoping review provides more flexibility and allows for diverse, relevant literature and 
studies using different methodologies [17,39,40]. Our research domain is adequate for 
taking a scoping review since the literature regarding H4.0 is multidisciplinary and 
relatively new. 
To achieve our goal, we followed a standard scoping study procedure comprised of five 
steps: (i) identify the research questions, (ii) identify relevant studies, (iii) select studies, 
(iv) chart the data, and (v) collate, summarize, and report results. Immediately below, we 
detail each stage and the outcomes of our work. 
Identify the research questions 
 
As with most systematic literature reviews, scoping reviews start with a primary research 
question to focus the inquiry [15,16], guiding how to build the search strategies [17]. Our 
broad initial research question was "How have healthcare institutions assessed their H4.0 
investments?". However, given the multidisciplinary nature of the subject and the 
comprehensive sources of reports, we narrowed the main research question into three 
more specific research questions:  
RQ1. What methodologies healthcare institutions use for evaluating investments in H4.0? 
RQ2. Which are the main challenges that healthcare institutions face when evaluating 
investments in H4.0? 
RQ3. Which are the most important characteristics that methodologies for evaluating 
investments in H4.0 must have? 
To answer these questions, we develop a rigorously structured and sufficiently 
documented method to provide robust evidence and arguments. 
Identify relevant studies 
 
A scoping study requires identifying all relevant literature, regardless of methodological 
design [16]. This step aims to find all available published and unpublished work that 
addresses the research questions, operationalized through the search terms. Since 
familiarity with the research topic is likely to increase as the review advances, we 
searched for relevant studies in two stages. In the first stage of identification, in order to 
include as many relevant studies as possible, we defined the set of keywords that best 
represents the scope of the study. In the second inclusion stage, we randomly selected a 
group of papers from each database and analyzed their keywords to determine the need 
to add more keywords to our inquiry. This two-stage process allows us to address the 
search string's potential problem of being overly specific or entailing (partially) 
misleading buzzwords.  
In the first stage, we defined the three research dimensions or keywords that best reflect 
our research questions: investment, health, and Industry 4.0. We then proceed to combine 
an initial set of keywords using AND and OR boolean search operators ("investment" 
AND "health," "health" AND "industry 4.0", "investment" AND "industry 4.0", "health 
technology assessment" AND "industry 4.0") to retrieve publications that used them in 
the title, abstract and/or keywords. The use of the AND operator in the search process 
significantly reduced misleading results, especially in the case of the "4.0" string. We 
searched for scientific articles in the following databases: Crossref, PubMed, Scopus, and 
Web of Science (that comprises biomedical literature from MEDLINE, life science 
journals, and online books).  
Since H4.0 derives from principles and technologies from I4.0, whose concept was 
formally acknowledged in 2011 [41], we only considered publications after that year. 
Further, in the widely referenced literature review study due to [3], the authors indicated 
that, even though the announcement of the I4.0 concept traces back to April 2011, it began 
to attract attention only after it became one of the ten official projects within the 'High-
Tech Strategy 2020' action plan, in March of 2012. In fact, no study was identified before 
that date, supporting the choice of cut-off year of 2011 for our scoping review. 
We applied the query string to the indicated databases and retrieved a total of 5701 
publications from all databases.   
In the second stage, we randomly selected five articles from each database to compare 
their keywords with the ones from the research dimensions used in the first stage [42]. 
The objective was to take into account that different taxonomies may be associated with 
a given subject, potentially compromising the search. From the comparisons, we 
identified the need to add the keywords "smart" to our inquiry. A new search , including 
those keywords, generated 74 additional papers, totaling 5,775 publications scattered 
among the databases as informed in Figure 1. We conducted both search stages between 
July and August 2020. Figure 1 reports the process of identification of relevant studies 
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The definition of different inclusion/exclusion criteria was post hoc, as the researchers' 
familiarity with the literature increased. In the first exclusion process (screening), we 
considered only articles in English published in peer-reviewed journals. We removed 
duplicate publications from the portfolio, which reduced from the initial 5,775 to 4,794 
articles. In the next exclusion step, paper titles were individually verified, determining 
their alignment with the research topic. That resulted in 4,475 paper titles deemed not 
relevant to the research. The remaining 319 articles that passed the title screening were 
then checked for alignment of keywords and abstracts with the research topic. 75 articles 
were excluded, resulting in 244 to be considered in the eligibility step.     
The next step is to determine the eligibility of the papers. Best practice guidelines for 
conducting scoping reviews recommend that two separate reviewers should carry out the 
literature search and sifting process. They must both agree for the work to be included. 
Therefore, we took special care to assure inter-rater reliability, with at least two separate 
reviewers involved in the process. 
We carried out the two separate review processes and performed a full-text analysis of 
244 articles to determine their eligibility. Fifty articles were identified as fully aligned 
with our research interests by both reviewers. We then proceed to evaluate the papers 
regarding the criteria of relevance and methodological rigor. In this process, we added a 
third reviewer, and a majority vote determined the inclusion of a paper. By the end of this 
stage, 30 articles were considered appropriate for inclusion in the review. We also 
analyzed those articles' references to identify relevant studies not yet included in the 
portfolio, but none was found. However, based on experts' recommendations (qualitative 
analysis), three articles were added to the portfolio, leading to a final number of 33 studies 
in the publications' portfolio, as displayed in Figure 1. 
Chart the data 
 
We will now chart and interpret critical data from the publication portfolio to establish 
the grounds for the subsequent analytical step [39]. We followed a descriptive-analytical 
method [17,43], providing a broader and meaningful view of all papers and collecting 
standard information from each study. Driven by our investigation's research questions, 
we organized the articles in a spreadsheet including the following information: authors, 
year of publication, journal, aims, type of technology, application focus (e.g., hospital 
processes or health treatments), valuation methods, decision-maker, users, challenges and 
opportunities. 
Figure 2 reports the histogram with the basic descriptive numerical summary of the 
publication count per year. Three main characteristics are noteworthy. First, as expected, 
studies on H4.0 financial evaluation are recent. Second, there is a slight increase in the 
number of publications in recent years (2018-2020). Finally, the number of publications 
is relatively small (33), which may be due to the novelty of H4.0, the multidisciplinary 
nature of the investment evaluation requirements, and its complexity. These findings 
reinforce the convenience of taking a scoping review approach. 
 
Figure 2: Evolution of the number of publications 
 
Collate, summarize and report results 
 
In this step, results are collated, summarized, and reported based on a thematic 
framework, such that a narrative account of the publication portfolio becomes available. 
Following [39], we carried out three complementary analyses to increase this step's 
consistency. First, we performed a descriptive thematic analysis to collate and summarize 
results. Second, based on reported results, we develop a detailed analysis of 
characteristics, contributions, and challenges on H4.0 evaluation tools. We report this 
analysis in section 4. In section 5, we describe an emerging framework that synthesizes 
the analyzed papers' empirical patterns. Finally, we discuss our findings' implications in 
a broader context, ensuring the scoping study methodology's legitimacy for both theory 
and practice [39]. In that discussion, we also listed research gaps and proposed research 
alternatives for future studies. 
We now expand on the first step, providing detailed information on key publications' 
characteristics. For that, we conducted a word cloud analysis using the title, keywords, 
and abstracts of papers in the portfolio. Figures 3 to 5 and Table 1 include the results, 
which provide initial evidence to answer the research questions. "Health" was the most 
frequent word, followed by "cost," "cost-effectiveness," "study," "evaluation," "care," 
"patients," and "data."  
 
 
Figure 3: Cloud analysis using titles as input. 
 
Figure 4: Cloud analysis using keywords as input. 
 
Figure 5: Cloud analysis using abstracts as input. 
 
The word cloud analysis anticipates the interdisciplinary nature of the manuscripts in the 
portfolio, allowing us to identify cost-effectiveness evaluation as the most recurrent. 
Besides, the incidence of the words "management," "clinical," and "patient" anticipates 
the need for healthcare institutions to incorporate a broad set of players in the investment 
decision process. We emphasize the absence of words such as quality, value, and bundle, 
which anticipate challenges and opportunities in current research on H4.0 investment 
analysis. 
 
Table 1: Most frequent words in Titles and Abstracts 
 
Figure 6 reports the top 15 most frequent authors in the portfolio and the number of 
documents they authored, showing some of those that authored just one paper and the 
entire list of those that authored two or more. From the list of 146 authors, one participated 
in three studies, two participated in two studies, and the remaining 143 appeared in only 
one article. A large number of authors with small authoring prominence is typical of 
research topics about which knowledge is still incipient, such as H4.0 investment 
evaluation, reinforcing the convenience of adopting a scoping review as the 
methodological approach. We also observe a large average number of authors per 










Figure 6: Top 15 authors and frequency of appearance in publications. 
Word Count Word Count
health 12 health 31
evaluation 10 results 26
cost 8 methods 24
cost_effectiveness 7 study 23
effectiveness 7 analysis 20
study 7 based 19
based 5 care 19
decision 5 data 17
economic 5 background 16
management 5 cost 16
Title Keyword
 
The journals' analysis also reinforces the topic's multidisciplinary nature. Figure 7 reports 
the number of papers by category and Figure 8 by journal. The Web of Science category 
"Health Care Sciences & Services" has the highest frequency of 15, followed by "Medical 
Informatics" (10), and "Pharmacology & Pharmacy" (2). Remaining seven categories 
display a frequency of 1 (70% of the sample). Two journals published four manuscripts 
each: Journal of Medical Internet Research and JMIR MHealth and UHealth.  
 
Figure 7: Frequency of manuscripts stratified according to Web of Science category. 
 
Figure 8: Frequency of manuscripts by journal. 
 
Analysis of Results 
 
Table 2 summarizes the papers listed in the rows by year of publication and their different 
content characteristics. We start reporting the type of technology analyzed, grouping them 
according to their role within the healthcare organization. Aceto et al. [5] proposed four 
interrelated subsets: (i) communication, (ii) sensing, (iii) processing, and (iv) actuation. 
Communication involves different interactions and disseminating health-related 
information, supporting patient-professional relationships, and collaborative care. 
Related H4.0 technologies provide support to increase accessibility, exchange, and 
sharing of information. Sensing refers to acquiring information about a patient, 
equipment, material, or process without necessarily making physical contact with them. 
Processing refers to technologies that may change or process the acquired data producing 
actual information in any manner detectable by an observer. Finally, actuation refers to 
technologies responsible for moving and controlling a system, mechanism (electronic or 
mechanical), or software based on the information and signals received. 
There may be overlaps between the technology subsets. Following the classification in 
[44], we further grouped H4.0 technologies into two bundles according to their role within 
the hospital: sensing-communication (reported under the column labeled "sensing") and 
processing-actuation (reported under the column labeled "actuation"). Consistent with 
previous studies' reports on the incidence of technological applications (e.g., [1]), the 
number of articles evaluating sensing-communication is significantly greater than those 
analyzing processing-actuation. Besides, and somehow paradoxically given the nature of 
H4.0, most studies focus on just one technology, with only six manuscripts addressing 
bundles of technologies. 
Regarding the thematic analysis (data not included in the table due to space limitations), 
we observe two groups of studies on H4.0 evaluation in healthcare organizations: those 
related to (i) health treatments and to (ii) hospital's supporting/administrative processes. 
Articles in group (i) are relatively more frequent than those in group (ii). 
The evaluation of different technologies contributes to health improvement in various 
manners. H4.0 technologies contribute to disease reductions such as cancer [45,46] and 
allow for better connectedness that manages individual and community health holistically 
by leveraging various technologies [47]. Connectedness can also incorporate telehealth 
and integrated care services, covering the whole spectrum of health-related services 
addressing healthy subjects and chronic patients [47]. Besides, neural networks improve 
decision-making, improving care delivery at a reduced cost [48]. 
The analysis above allowed us to describe types of technology and the health 
improvement aimed by their use. We now address the first research question. For that, 
we survey what methodologies healthcare institutions reportedly use for evaluating 
investments in H4.0. 
Regarding the different methodologies for evaluating investments in H4.0, only 14 
(42.4%) of the 33 papers analyzed presented valuation methods, 7 of which (21.2%) 
focused on cost valuation methods, and 7 (21.2%) on value methods. Regarding forms of 
considering uncertainty in the analysis, 2 (6%) used deterministic techniques which 
disregard uncertainties, 5 (15.2%) accounted for uncertainty but did not use real options, 
and 7 (21.2%) accounted for uncertainty using a real-options approach.  
As we can observe, studies that consider the cost implications of investing in H4.0 focus 
on economic analysis, adopting a cost-effectiveness and cost-minimization perspective. 
These studies were complemented by the application of Bayes sequential economic 
evaluation model for health technologies in which an investigator has flexibility over the 
timing of a decision to stop carrying out research and conclude that one technology is 
preferred over another on cost-effectiveness grounds [49]. Five manuscripts took a real-
options perspective that incorporates value considerations but refers to past work, mainly 
published at the beginning of the time window of analysis. 
The portfolio of 33 works lists three types of decision-makers, which may be consulted 
individually or in groups: doctors, administrative, and patients. Doctors appear in 27 of 
the 33 documents, complemented by 13 papers that incorporate the administrative 
perspective and 7 containing the patient perspective. Although there is a dominance of 
expert opinion based on medical advice, the variety of decision-makers is a positive result 
that further claims for a multidisciplinary analysis that incorporates the different types of 
users affected when evaluating investments in H4.0. Users of the information derived 
from the evaluations are also doctors, administrative, and patients; however, 
administrative users are predominant since they are direct users of the economic 
information. 
A relevant aspect of the works analyzed in the portfolio is that 16 articles present results 
of scoping or systematic literature reviews and meta-analysis (in one of them). However, 
they focused on the medical convenience of H4.0 investments, not exploring specific 
economic evaluation tools, and mainly assessing a particular technology (e.g., physicians' 
adoption of e-health technology or smart device applications for older adults).   
We were able to consolidate several relevant propositions for the economic evaluation of 
H4.0 technologies. A fundamental contribution of our review is identifying the main 
antecedents of hospital investment decisions in technology, such as the healthcare system, 
the socio-economic and cultural context, and its mission [13,14]. Regarding the 
healthcare system, findings emphasize the role of health insurance coverage, financing 
method, reimbursement method for hospitals, payment method to physicians, and hospital 
ownership as antecedents of H4.0 investments. The existence of these various antecedents 
anticipates the challenges of investment evaluations. 
 









Actuation Cost Value Cost Value Cost Value
2011 Dreyfuss & Roberts [45] X X X X X
Grutters et al. [73] X X X X X
2012 Marsh et al. [74] X X X X X X X
2013 Favato et al. [75] X X X X
Drummond et al. [50] X X X X X
Pertile et al. [49] X X X X
2014 Boydell et al. [51] X X X X X
Kvedar et al. [52] X X X X X X X
Wernz et al. [14] X X X X X X X
2015 Atwood et al. [53] X X X X X X X
Wernz et al. [13] X X X X X X
Gobbi & Hsuan [55] X X X X X
Merlo et al. [56] X X X X X X
2016 Sharma et al. [57] X X X X X
Matthew-Maich et al. [58] X X X X X X
de Grood et al. [37] X X X X X X
2017 Lavallée et al. [59] X X X X
Kim & Lee [60] X X X X X X
Rejeb et al. [46] X X X X X
Greenhalgh et al. [61] X X X X X X
2018 Long et al. [62] X X X X
Adjekum et al. [63] X X X X
Winters et al. [64] X X X X X X
Baines et al. [65] X X X X X X X
2019 Taj et al. [66] X X X X X
Dogba et al. [67] X X X X X X
Loncar-Turukalo et al. [68] X X X X X X
Shahid et al. [48] X X X X X
Wüller et al. [69] X X X X X
Chouvarda et al. [47] X X X X X
2020 Hasselgren et al. [70] X X X X X
Peng et al. [71] X X X X X X




Medical Administrative PatientStand Alone Bundle/Portfolio
Technologies Valuation Methods
Deterministic Uncertainty No Option Uncertainty Option Analysis
User
Medical Administrative Patient
The appropriate deployment of medical technology should help contribute to the quality 
of healthcare delivered, improve access to information, and contain costs [53]. Among 
the most promising evaluation alternatives is the framework in [61] to assist 
implementation teams in identifying, understanding, and addressing the interacting 
challenges to achieving sustained adoption, local scale-up, distant spread, and long-term 
sustainability of their technology investments in hospitals. Complementing this analysis 
is the call for applying a simple, multiattribute rate technique in the valuation process – 
SMART, as proposed in [13]. 
We identified four main challenges that healthcare institutions face while evaluating 
investments in H4.0. First, H4.0 should be analyzed as a bundle of technologies rather 
than individual solutions. As [5] proposes, there are four overlapped groups of 
technologies based on their roles and applicability within the hospital. In our portfolio, 
only 6 (18.1%) of the papers analyze H4.0 as a bundle. Second, as mentioned earlier, 
there is a research gap on valuation methodologies for H4.0 technologies, especially in 
the realm of real-options analysis. Third, regarding who makes the decision to acquire the 
technology (medical, administrative, or patient), 27 studies (81.8% of the sample) focus 
on the medical personnel as the main decision-makers. In contrast, only 8 (24.2%) focus 
on patients, and a single paper integrates the three actors in the process [56]. Fourth, 
regarding the user of the technologies, 22 studies (66.6%) focus on the medical personnel, 
while 8 papers (24.2%) indicate that the main user is the patient. 
Real-options strategies offer a transparent method for weighing the costs and benefits of 
adopting and further researching new and expensive technologies [45,73]. Such valuation 
methodologies incorporate the value of future new information in current analyses. 
Articles in the portfolio report real-options applications in proton therapies' adoption 
analysis [45,73], and helping to formulate better human papillomavirus vaccination 
strategies [75]. Surprisingly, none of the articles using real-options analysis incorporate 
uncertainty correlations among technological bundles. That is a critical shortcoming 
given antecedents that reports the importance of taking broader portfolio considerations 
when evaluating related and uncertain investments in areas such as biotechnology R&D 
[76]. 
Healthcare managers often make purchasing decisions without adequately assessing the 
resource demands, up-front costs (including integration costs), workflow impact, 
reimbursement potential, and other factors needed to fully understand the value added by 
new medical technology [53]. Consequently, healthcare authorities may risk failing at 
conducting thorough due diligence before purchasing medical technology. Under these 
circumstances, organizations might add unnecessary costs to their budget without adding 
significant clinical or operational value. 
Selecting new medical technology for a healthcare organization can be a daunting task. It 
is crucial to implement a systematic approach for evaluating the latest medical 
technology, starting with a clearly articulated need for the technology. If organization 
authorities are unwilling to assess and redesign processes to utilize the new medical 
technology fully, investment withholding may be the most suitable course of action. 
Moreover, there is the risk of bias in purchasing the latest technology simply because it 
is available [53]. Overall, healthcare organizations rarely assess a systematic decision 
process that considers all organizational objectives and analyzes and integrates 
comprehensive data [53]. 
Providing universal access to innovative, high-cost technologies leads to tensions in 
today's healthcare systems. The stress becomes particularly evident in the context of 
scarce resources, where the risk of taking contentious coverage decisions increases 
rapidly. If healthcare institutions intend to maintain sustainable access to H4.0 in the 
future, they will need new approaches to reconcile these different perspectives [50]. 
Overall, while policymakers request a rapid and at-scale technology implementation, the 
reality is that when dealing with the multiple complexities of health and care, it is 
challenging to go beyond small-scale demonstration projects [53]. To address the need 
for new approaches, we propose in the next section a framework for the evaluation of 
H4.0 technologies in hospitals. 
Classification Framework 
 
Scientific research presents frameworks since managers use them to support their analysis 
and provide validity to the decision-making process [77]. We develop an emerging 
framework from the study we carried out about the research on hospital evaluations of 
H4.0.  
Developing frameworks has multiple advantages. They decrease the number of 
uncertainties when addressing a new phenomenon, as is the case of H4.0. Frameworks 
can support the selection of investment strategies. Besides, frameworks can depict 
features of various phenomena [78], compare and guide numerous organizational 
practices [79], support the execution of tasks [80], and refute or confirm a particular 
management approach [81].  
When developing the framework, it is fundamental to determine the rationale that 
provides validity to the theoretical process. Given the scoping review's multidisciplinary, 
integrative nature, we have taken a process of abstraction. That is, we obtain higher-order 
themes from lower-order elements [82]. We follow, therefore, the most common 
abstraction process, in which lower-order themes are a function of the findings of 
individual studies, and higher-order structures link and organize the lower-order themes 
[82]. Such a method should result in the advancement of knowledge rather than a simple 
overview or description of a research area [83]. That is, it should not be descriptive or 
historical but should preferably generate a new conceptual framework. In addition, check 
the reliability of higher-order themes using a focus group of experts. It is worth noting 
that the higher-order themes respond to taxonomy and not from a typological process 
[83,84].    
Figure 9 presents the proposed classification framework. It focuses on the most 
fundamental tensions that organizations face when analyzing H4.0 investments and 
reflects the most prominent features of our manuscripts' portfolio. We categorized the 
type of technology analyzed based on its focus, sensing-communication or processing-
actuation, following the classification in [1]. In this process, we classify lower-order 
themes into higher-order classification. We describe the number of technologies 
evaluated, depending on whether the analysis refers to stand-alone technologies or 
bundles. We also report the evaluation method, saying whether it is just based on cost or 
also taking into account value considerations. We considered whether the analysis does 
not incorporate flexibility in the valuation process or explicitly incorporate it using a real-
options approach. We also examine the portfolio of manuscripts regarding the variety of 
decision-makers included and the type of technology users. For all of these cases, we 
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Figure 9: Classification framework. 
The framework not only helps to classify a particular research paper but also has utility 
for practice. It may allow hospital authorities to understand what type of organizational 
process they have in place to analyze investment decisions in H4.0. Also, it helps to 
anticipate the complexity of the task. When reflecting on the most critical tensions 
hospitals face, the structure would allow authorities to detect the underlying leadership 
and change management challenges.  
When categorizing the portfolio of manuscripts using the proposed framework, we 
identified a significant concentration of studies on the left side. It seems reasonable to 
observe such unbalanced distribution, given the developing nature of H4.0. However, it 
also signals an essential shortcoming of the current literature, directing further research 
propositions. There is a risk that hospitals might have been making decisions following 
an isomorphic behavior [85] which is not necessarily the best rational approach. Research 
concentration might reflect a herding behavior in which hospitals imitate one another 
instead of following a robust, innovative path.   
We further analyze the framework and develop a research opportunity map, displayed in 
Figure 9, focusing on two dimensions of the framework: the complexity of the analysis 




















Figure 10: Research opportunity map 
 
From the research map it is possible to indicate that there is a research opportunity related 
to analyzing bundles of technologies with complex relationships which incorporates 
uncertainty correlations. It is important to emphasize that complex relationships do not 
necessarily imply more complex analyses. The challenge is to integrate a higher level of 
complexity with straightforward analytical tools. We will return to this point at the end 
of the following section. 
Research directions 
 
This section addresses the third research question; that is, we identify the crucial 
characteristics that methodologies for evaluating investments in H4.0 should have. These 
characteristics also represent research gaps that future research needs to address. 
Overall, we anticipate that the evaluation of H4.0 presents similar challenges and 
opportunities compared to general technology investments, although more complex due 
to the nature of H4.0 technologies. We also observe that the existing research does not 
entirely succeed in helping hospitals in the investment decision-making process, leading 
to promising research opportunities. 
Insufficient economic valuation of H4.0 investments  
 
Decades of research on health technology assessment (HTA) resulted in a framework that 
includes economic evaluation as a fundamental pillar. However, the list of manuscripts 
that integrates this economic perspective rigorously is still scarce. Advancements focus 
more on cost-effectiveness than economic value, at a public policy level rather than at the 
hospital level. Besides, studies confirmed that health care institutions rarely apply a 
systematic analysis that considers all organizational objectives and integrates 
comprehensive data [13]. For instance, among the shortcomings of economic analysis is 
the relatively low commercial externalities valuation. 
Although some older studies on real options include cost and value considerations, more 
recent propositions tend to overfocus on cost analysis, imposing a challenging bias on 
investment decisions. Among propositions that incorporate value, the net present value 
analysis is the most frequently used, often resulting in a sub-optimal decision, as it does 
not consider the value of future options and managerial flexibility [13]. Usually, simple 
cost-benefit analysis and subjective assessment replace sophisticated analytical methods 
and objective data, at the risk of not investing in more expensive technologies with higher 
health impacts due to their investment requirements. The development of real-options 
approaches that include value considerations targeted at evaluating investments in H4.0 
technologies is a promising research opportunity that should resonate positively among 
practitioners. 
Explicit assessment of technological interrelationships  
 
The literature provides evidence that for maximizing the return on H4.0 investments, 
hospitals should consider them in bundles. Studies proposed distinct bundles (or 
groupings) of H4.0 technologies. Sharma et al. [57] categorized technologies into three 
bundles according to their extent of patient-centered integration and caregiver interaction. 
[5] conceptually proposed four overlapped groups of technologies based on their roles 
and applicability within the hospital. Gastaldi and Corso [86] proposed another 
categorization of H4.0 technologies dividing them into four macro-areas, further 
subdivided into fourteen solutions provided by each technology. Finally, [87] suggested 
a taxonomy to classify wearable technologies in healthcare systems according to three 
major dimensions: application, form, and functionality.  
Even though the literature still lacks consensus on the correct taxonomy of bundles of 
H4.0 technologies and how to combine them to act synergistically, it is clear that 
valuation should incorporate the bundling of technologies. For that, researchers and 
institutions need to assess portfolio effects explicitly [76]. The literature in real options 
includes several studies that explicitly address portfolio considerations [76,88–90], 
providing a potential area of extension to H4.0 technological investments. In analyzing 
hospital investments, research incorporating portfolio considerations is scarce (e.g., [13]) 
and does not include real-options valuations. It is fundamental to understand if investing 
in technologies' bundles creates super and subadditivity [76], altering the net economic 
contribution of different alternatives and, eventually, changing the suggested priorities. 
We detected recent efforts to provide an accessible and usable framework that would 
enable multiple objectives, mainly developed by authors seeking to design, develop, 
implement, scale-up, spread, and sustain technology-supported health or social care 
programs to identify and help address the critical challenges in different domains and the 
interactions between them [52,61,68]. However, developments only start to address the 
shortcomings identified in our scoping review, opening opportunities for future research. 
Incorporate fundamental uncertainties  
 
Healthcare 4.0 technologies enhance efficiency and quality in healthcare systems. 
However, fundamental uncertainties exist on the definition of the industry standards on 
many of those technologies, creating uncertainty when evaluating investments. Factors 
that add additional complexities to technological advancements relate to uncertainty on 
patient demands and competition [13].  
To reduce the risk of investing in a technology that ends being crowded out and not 
adopted as the standard, hospitals have several alternatives; further research is needed to 
explore their viability. Surprisingly, the discussion about standards is scarce in the 
economic evaluation of H4.0 technologies, with the main focus still being on their 
efficacy. 
Integrating administrative, medical, and patient perspectives in the evaluation process 
 
The fourth research opportunity relates to integrating medical, patient, and administrative 
considerations in the valuation process. We already stressed that interrelationships among 
technology bundles incorporate non-trivial challenges. On top of that, institutions should 
consider the risk of investing in technologies that fail to establish the industry standard.  
The final layer is to balance medical benefits with economic costs adequately. It is still 
unclear how to achieve such reconciliation [50]. The central problem is how to merge 
different logics. On one side, doctors favor technologies with the most promising medical 
effects, regardless of uncertainty and varying requirements of investments and costs. On 
the other side, the administrative staff needs to ensure the hospital's economic viability. 
Under high levels of uncertainty, the amount of investment and the operating costs (i.e., 
the economic logic) might contradict the medical logic. Research is needed to explore the 
most suitable ways that hospitals have to coordinate both perspectives. 
In integrating into the valuation process the different perspectives, hospitals need to 
include that of the patient for at least three reasons [50]. First, a comprehensive 
assessment should consider patients' views about satisfaction and acceptability of health 
technologies. Second, with chronic forms of disease and disability, patients and their 
families play a more active part in healthcare decisions. Patients' lifestyles and behaviors 
may dramatically influence long-term prognoses of chronic conditions. Third, involving 
patients increases transparency and openness in public policy [50]. We acknowledge that 
incorporating the patient's view in the investment decision analysis will add a layer of 
complexity in a process that is already difficult to manage. However, any valuation 
analysis that considers costs and value without including the patient perspective will be 
incomplete. 
The integration of different perspectives provides an opportunity to cross-fertilize 
research on H4.0 investments with adaptive leadership tools [91]. Alternatively, the 
incorporation of H4.0 technologies equals establishing a dynamic organization capability 
that demands from employees the ability to leverage interpersonal relationships 
conducive to productive dialogue [92].  
Remain manageable in the decision-making process 
 
Antecedents describe hospitals' investment decisions as ad-hoc, informal, political, 
without enough data analysis, and not aligned with the institutions' mission and strategy 
[13]. We argue in favor of assessments that explicitly consider technological 
interrelationships, incorporate fundamental uncertainties, and integrate administrative 
and medical insights. However, our claim comes with an essential restriction: analytical 
methods should avoid introducing complex evaluation tools that hamper the hospital's 
decision-making process.  
At first, such a requirement seems challenging. We claimed to incorporate bundles of 
technologies, map multiple uncertainties, consider value implications and not exclusively 
cost aspects, and include different stakeholders' perspectives. A priori, these requirements 
go against the simplification of the decision-making process. However, it might be 
possible to solve this tension by articulating the valuation process in different stages. We 
envision a lean financial valuation that combines those competing demands without 
drastically complicating the decision process.   
Lean financial valuation of H4.0 investments involves simplifying, streamlining, and 
harmonizing essential valuation processes to create a leaner, more efficient valuation 
operation. The current research opportunity relates to developing lean organizations that 
incorporate valuation tools that simultaneously address challenges such as complex 
uncertainty relationships and bundle effects into organizational structures that adjust to 
lean principles. 
Limitations and final remarks 
 
This research examined how hospitals approach investment decisions in H4.0 by using a 
scoping review of the existing literature. For that, we searched for journal articles in four 
databases and screened relevant contributions to consolidate a publications' portfolio on 
the topic, following predefined criteria. Results of the scoping review were explored 
through: 
1. A descriptive numerical summary and thematic analysis; 
2. Identification of trends and challenges in H4.0 investment evaluation; 
3. Proposition of a classification framework for H4.0 investment evaluation; and 
4. Identification of research opportunities and proposition of future research 
directions from a hospital investment management point of view. 
Despite the subject's recency, we observed that research in H4.0 expands 
interdisciplinarily with a diversified set of applications and functionalities. In terms of the 
economic evaluation, manuscripts on H4.0 tend to overfocus on cost considerations and 
underemphasize cost-value relationships. Studies that consider both sides of the economic 
valuation (i.e., value and cost) use real-options analysis and tend to be older in the sample 
of manuscripts analyzed. Although impacts of H4.0 adoption substantially increases 
when hospitals adopt technologies in bundles, research mainly focuses on the analysis of 
single technologies. Finally, recent manuscripts call for an integration of different actors 
in the decision process by developing a comprehensive, consistent, and data-driven 
framework for evaluating hospitals' investment decisions. We propose a framework that 
serves as a starting point. 
Some limitations in our study are noteworthy, mostly related to its nature and 
methodological choices. Since I4.0 has been formally acknowledged in 2011 and H4.0 is 
a concept derived from it, our scoping study only encompassed publications after that 
year. However, it is worth mentioning the existence of initiatives aimed at valuing I4.0 
technologies in heathcare systems not characterized as such,dating earlier than 2011, 
which is a limitation in our research. Nevertheless, as studies before 2011 were scarce 
and scattered, and the number of publications on the topic has significantly increased in 
the past few years, we believe that our choice of search period returned all relevant works 
on H4.0.  
A second limitation is that we focused our literature analysis and discussion on H4.0 
evaluation within hospitals. However, the concept of healthcare has expanded and gone 
beyond the limits of healthcare organizations (i.e., hospitals and clinics). In fact, with the 
advent of 'smart cities', complementary aspects of healthcare have been integrated due to 
the increased level of interconnectivity and data acquisition, allowing to demand 
healthcare services remotely. Our study did not analyze those aspects and exclusively 
considered hospitals as units of analysis.  
Third, it is worth emphasizing that we combine insights from two perspectives for 
developing the proposed framework: the state-of-the-practice at hospitals and the state-
of-the-art in the literature. However, our main focus has been on research, and we did not 
include a specific survey of empirical studies mapping hospital tools. That is 
simultaneously a limitation of our investigation and a research opportunity. 
Finally, identifying trends, challenges, and theoretical gaps through this scoping review 
allows us to develop a framework. However, we acknowledge that this is a first step 
towards the proposition of an in-depth framework. Future studies could use the theoretical 
consolidation of the literature in our study as a conceptual subside for developing such a 
detailed H4.0 evaluation framework. We hope that our classification framework will act 
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